CSIR in the news..

An aggregation of news on the web about CSIR and its laboratories

CSIR launches herbal anti-diabetes drug ‘BGR-34’ in India

28 October 2015

An anti-diabetes herbal drug, jointly developed by two Council of Scientific and Industrial Research (CSIR) laboratories has been launched in certain parts of North India. The drug, dubbed BGR-34, has been derived from the medicinal plant extracts as described in the ancient Ayurveda text.

BGR-34 been jointly developed by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP). For the purpose of commercialisation, the drug licence has been awarded to Delhi-based Aimil Pharamaceuticals Pvt. Ltd. In return, Aimil will pay royalty based on drug sales to CSIR.

Source: http://www.ibtimes.com.au/csir-launches-herbal-anti-diabetes-drug-bgr-34-india-1478719

Advertisements

Written by csirindia

October 29, 2015 at 9:59 am

Posted in CIMAP, NBRI

%d bloggers like this: